SMO and hepatocellular carcinoma: Others found a mutation in the C-terminal lysine (K575M) that allows for SMO to act independently of PTCH1 as it is unable to bind to and inhibit SMO, leading to uncontrolled signalling and expression of stem cell renewal genes in hepatocellular carcinoma cells (HCC) [134,135].